The parent Bcl-2 protein is an apoptosis suppressor that is found to be frequently overexpressed in cancer cells [1], and the therapy-resistant cancer phenotype is commonly induced by the overexpression of anti-apoptotic Bcl-2. This evidence concerns the gene BCL2 and cancer.